Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,497 | 48,705 | 57,221 | 64,508 | 21,352 |
| Receivables | 0 | 0 | 0 | 1,001 | 1,001 |
| TOTAL | $45,982 | $51,407 | $60,024 | $67,471 | $24,411 |
| Non-Current Assets | |||||
| PPE Net | 10,097 | 9,847 | 10,108 | 10,298 | 3,571 |
| Other Non-Current Assets | 12,056 | 10,686 | 10,340 | 10,593 | 17,633 |
| TOTAL | $22,153 | $20,533 | $20,448 | $20,891 | $21,204 |
| Total Assets | $68,135 | $71,940 | $80,471 | $88,362 | $45,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,135 | 7,645 | 5,101 | 3,674 | 6,013 |
| TOTAL | $12,902 | $8,227 | $5,660 | $4,147 | $6,402 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,146 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 11,248 | 11,431 | 11,568 | 11,720 | 11,868 |
| TOTAL | $11,248 | $11,431 | $11,568 | $11,720 | $11,868 |
| Total Liabilities | $24,150 | $19,658 | $17,228 | $15,867 | $18,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,308 | 8,308 | 8,308 | 8,301 | 5,073 |
| Common Shares | 8 | 83 | 83 | 83 | 51 |
| Retained earnings | -398,118 | -388,355 | -375,926 | -365,019 | -356,240 |
| TOTAL | $43,986 | $52,282 | $63,243 | $72,495 | $27,345 |
| Total Liabilities And Equity | $68,135 | $71,940 | $80,471 | $88,362 | $45,615 |